Fly News Breaks for November 7, 2019
Nov 7, 2019 | 10:10 EDT
SVB Leerink analyst Daniel Grosslight called Livongo Health's "strong beat and raise" third quarter report "a welcome surprise" after what he views as an unwarranted sell-off in the stock after a second quarter earnings report that he describes as "benign." His talks with management post-earnings and the company's more transparent backlog metrics give him "even more confidence" in his Livongo estimates for 2020 and beyond, added Grosslight, who keeps an Outperform rating on the stock with a $50 price target.
News For LVGO From the Last 2 Days
There are no results for your query LVGO